Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial. (nature.com)

Authors: Rosenstock J … Coll B Journal: Nature Medicine Published: 2026-06-05 DOI: https://doi.org/10.1038/s41591-026-04476-6